Phase I Study of ICP-332 in Healthy Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Subjects

In brief

A multiple ascending dose phase I study of ICP-332 in healthy subjects

Key facts

Study ID

NCT06530966

Run by

InnoCare Pharma Inc.

People needed

24

Starts

2024-07-23

Expected to finish

2024-11-08

Last updated by the study team

2026-04-14

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Voluntarily sign the informed consent form
• Body mass index (BMI) of ≥ 18.5 kg/m2 and < 30 kg/m2
• Male or infertile female subjects who are between 18-55 years old (inclusive)

You may not qualify if…

• Significant current or past acute or chronic disease or condition.
• A history of tuberculosis or current active/latent infection.
• With a history of drug or food allergy, or allergy to any of the composition components of the study drug, or allergic disease.
• Subjects with clinically significant abnormalities in the screening examinations.

Where it is running

• Pharmaron CPC Inc. — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.